EN
Assessment of antioxidant and anticancer attributes of crude extracts from edible mushrooms Lycoperdon molle and Apioperdon pyriforme
Abstract
The study analyzed extracts from two mushroom species, Lycoperdon molle and Apioperdon pyriforme, for their phenolic and flavonoid compound contents, antioxidant capacities, enzyme activities, and cytotoxic effects against human colorectal and breast cancer cells. LM extract was found to contain higher levels of phenolic compounds, including catechin, gallic acid, and myricetin. While AP extract had a higher concentration of gallic acid. Both extracts exhibited antioxidant activity, with LM showing slightly higher DPPH radical scavenging rates. However, their activities were weaker compared to standard antioxidants like gallic acid and quercetin. Enzyme assays revealed that both extracts inhibited CAT activity, activated GPx activity, and induced SOD activity. LM extract also inhibited GST activity, while AP extract showed activation at a certain concentration. In terms of cytotoxicity against cancer cells, LM extract displayed greater efficacy than AP, with lower IC50 values for both HT-29 colon cancer cells and MCF-7 breast cancer cells. Overall, the study highlights the potential differential bioactive properties of LM and AP extracts, with LM demonstrating stronger antioxidant and anti-cancer effects.
Keywords
References
- [1]Chun S, Gopal J, Muthu M. Antioxidant Activity of mushroom extracts /polysaccharides -their antiviral properties and plausible AntiCOVID-19 properties. Antiox. 2021; 10(12):1899. https://doi.org/10.3390/antiox10121899
- [2]Nowakowski P, Markiewicz-Żukowska R, Bielecka J, Mielcarek K, Grabia M, Socha K. Treasures from the forest: Evaluation of mushroom extracts as anti-cancer agents. Biomed Pharmacother. 2021; 143:112106. https://doi.org/10.1016/j.biopha.2021.112106.
- [3]Chang ST, Wasser SP. Current and future research trends in agricultural and biomedical applications of medicinal mushrooms and mushroom products. Int J Med Mushrooms. 2018; 20(12):1121-1133. http://dx.doi.org/10.1615/IntJMedMushrooms.2018029378.
- [4]Venturella G, Ferraro V, Cirlincione F, Gargano ML. Medicinal mushrooms: Bioactive compounds, use, and clinical trials. Int J Mol Sci. 2021;22(2):634. https://doi.org/10.3390/ijms22020634
- [5]Dizeci N, Onar O, Karaca B, Demirtas N, Coleri Cihan A, Yildirim O. Comparison of the chemical composition and biological effects of Clitocybe nebularis and Infundibulicybe geotropa. Mycologia. 2021; 113(6):1156-1168. https://doi.org/10.1080/00275514.2021.1951076
- [6]Dimopoulou M, Kolonas A, Mourtakos S, Androutsos O, Gortzi O. Nutritional composition and biological properties of sixteen edible mushroom species. Appl Sci. 2022; 12: 8074. https://doi.org/10.3390/app12168074
- [7]Onar O, Telkoparan-Akillilar P, Yildirim O. Clitocybe nebularis extract and 5‑fluorouracil synergistically inhibit the growth of HT-29 colorectal cancer cells by inducing the S phase arrest. 3 Biotech. 2023; 13(2):48. https://doi.org/10.1007/s13205-023-03471-9
- [8]Kirk PF, Cannon PF, Minter DW, Stalpers JA, Dictionary of the fungi, 10th ed, CAB International. Wallingford, USA, 2008, pp.784.
Details
Primary Language
English
Subjects
Pharmacology and Pharmaceutical Sciences (Other)
Journal Section
Research Article
Publication Date
June 4, 2025
Submission Date
August 7, 2024
Acceptance Date
November 14, 2024
Published in Issue
Year 2025 Volume: 29 Number: 3
APA
Dizeci, N., Onar, O., & Yıldırım, Ö. (2025). Assessment of antioxidant and anticancer attributes of crude extracts from edible mushrooms Lycoperdon molle and Apioperdon pyriforme. Journal of Research in Pharmacy, 29(3), 1168-1175. https://doi.org/10.12991/jrespharm.1694325
AMA
1.Dizeci N, Onar O, Yıldırım Ö. Assessment of antioxidant and anticancer attributes of crude extracts from edible mushrooms Lycoperdon molle and Apioperdon pyriforme. J. Res. Pharm. 2025;29(3):1168-1175. doi:10.12991/jrespharm.1694325
Chicago
Dizeci, Naz, Okan Onar, and Özlem Yıldırım. 2025. “Assessment of Antioxidant and Anticancer Attributes of Crude Extracts from Edible Mushrooms Lycoperdon Molle and Apioperdon Pyriforme”. Journal of Research in Pharmacy 29 (3): 1168-75. https://doi.org/10.12991/jrespharm.1694325.
EndNote
Dizeci N, Onar O, Yıldırım Ö (June 1, 2025) Assessment of antioxidant and anticancer attributes of crude extracts from edible mushrooms Lycoperdon molle and Apioperdon pyriforme. Journal of Research in Pharmacy 29 3 1168–1175.
IEEE
[1]N. Dizeci, O. Onar, and Ö. Yıldırım, “Assessment of antioxidant and anticancer attributes of crude extracts from edible mushrooms Lycoperdon molle and Apioperdon pyriforme”, J. Res. Pharm., vol. 29, no. 3, pp. 1168–1175, June 2025, doi: 10.12991/jrespharm.1694325.
ISNAD
Dizeci, Naz - Onar, Okan - Yıldırım, Özlem. “Assessment of Antioxidant and Anticancer Attributes of Crude Extracts from Edible Mushrooms Lycoperdon Molle and Apioperdon Pyriforme”. Journal of Research in Pharmacy 29/3 (June 1, 2025): 1168-1175. https://doi.org/10.12991/jrespharm.1694325.
JAMA
1.Dizeci N, Onar O, Yıldırım Ö. Assessment of antioxidant and anticancer attributes of crude extracts from edible mushrooms Lycoperdon molle and Apioperdon pyriforme. J. Res. Pharm. 2025;29:1168–1175.
MLA
Dizeci, Naz, et al. “Assessment of Antioxidant and Anticancer Attributes of Crude Extracts from Edible Mushrooms Lycoperdon Molle and Apioperdon Pyriforme”. Journal of Research in Pharmacy, vol. 29, no. 3, June 2025, pp. 1168-75, doi:10.12991/jrespharm.1694325.
Vancouver
1.Naz Dizeci, Okan Onar, Özlem Yıldırım. Assessment of antioxidant and anticancer attributes of crude extracts from edible mushrooms Lycoperdon molle and Apioperdon pyriforme. J. Res. Pharm. 2025 Jun. 1;29(3):1168-75. doi:10.12991/jrespharm.1694325